A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression

Thyroid - United States
doi 10.1089/thy.2013.0680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

PLoS ONE
Multidisciplinary
2012English

NY-BR-1 Protein Expression in Breast Carcinoma: A Mammary Gland Differentiation Antigen as Target for Cancer Immunotherapy

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2007English

Potential Role of 5-Aza-2′-Deoxycytidine Induced MAGE-A4 Expression in Immunotherapy for Anaplastic Thyroid Cancer

Surgery
Surgery
2013English

NY-ESO-1 Antibody as a Novel Tumour Marker of Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Role of Chemokine Receptors in Thyroid Cancer and Immunotherapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Modulating Antigen Processing for Cancer Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2014English

NY-ESO-1 Antigen-Reactive T Cell Receptors Exhibit Diverse Therapeutic Capability

International Journal of Cancer
Cancer ResearchOncology
2012English

Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated With Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy